Skip to content

Optimization of EBV-T/NK-LPD Diagnostic Framework and Construction of the Prognostic Model of transformation and progression

Optimization of EBV-T/NK-LPD Diagnostic Framework and Construction of the Prognostic Model of transformation and progression

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000032594
Enrollment
Unknown
Registered
2020-05-03
Start date
2020-06-01
Completion date
Unknown
Last updated
2020-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

EBV-positive T/NK-cell lymphoproliferative diseases

Interventions

Case series:Nil

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Patients with leaflet like symptoms (including fever, pharyngeal pain, liver dysfunction, hepatosplenomegaly, lymphadenopathy, etc.) repeated or lasted for no more than 3 months; 2. Patients with or without hemophagocytosis; 3. Patients with increased peripheral blood EB virus load; 4. Patients with EBV related t / NK cell lymphoproliferative diseases (except STLC, enktl-n and ankl) were diagnosed pathologically.

Exclusion criteria

Exclusion criteria: 1. Patients whose course of disease is more than 1 month at the time of diagnosis of saebv; 2. Patients with other tumors; 3. Patients with other serious diseases (HIV infection, congenital or genetic diseases with risk of death).

Design outcomes

Primary

MeasureTime frame
Overall Survival;disease progression;mutations;gene transcription;

Countries

China

Contacts

Public ContactWeiping Liu

West China Hospital of Sichuan University

hxliuweiping@163.com+86 18980601641

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026